Related Research Articles
Cedars-Sinai Medical Center is a nonprofit,tertiary,886-bed teaching hospital and multi-specialty academic health science center located in Los Angeles,California. Part of the Cedars-Sinai Health System,the hospital has a staff of over 2,000 physicians and 10,000 employees,supported by a team of 2,000 volunteers and more than 40 community groups. As of 2022–23,U.S. News &World Report ranked Cedars-Sinai among the top performing hospitals in the western United States. Cedars-Sinai is a teaching hospital affiliate of David Geffen School of Medicine at the University of California,Los Angeles (UCLA),which was ranked in the top 20 on the U.S. News 2023 Best Medical Schools:Research.
Chandler Park is an American physician,medical journalist,and clinical researcher. In June 2021,his cancer research was published in prominent medical journals including the New England Journal of Medicine and Journal of Clinical Oncology. Park also contributes regularly as an expert physician for popular newspapers and magazines such as Newsweek,Reader's Digest,U.S. News &World Report,The Exponent-Telegram,College of St. Scholastica,and Medscape and writes medical news for Doximity. In 2020,Park was selected as the President of the Kentucky Society of Clinical Oncology. The Kentucky Society of Clinical Oncology is the state affiliate of American Society of Clinical Oncology,American Society of Hematology,and National Cancer Institute.
Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system,including ovarian cancer,uterine cancer,vaginal cancer,cervical cancer,and vulvar cancer. As specialists,they have extensive training in the diagnosis and treatment of these cancers.
David B. Agus is an American physician,cancer researcher and author who serves as a professor of medicine and engineering at the University of Southern California Keck School of Medicine and Viterbi School of Engineering and the Founding Director and CEO of the Lawrence J. Ellison Institute for Transformative Medicine. He is also the cofounder of several personalized medicine companies and a contributor to CBS News on health topics. He is also the author of four books.
Jonathan S. Berek, MD MMS is the Laurie Kraus Lacob Professor at the Stanford University School of Medicine,Director of the Stanford Women's Cancer Center,and Senior Advisor,Stanford Cancer Institute. He is a recent past Fellow in the Stanford Distinguished Careers Institute.
Kelly J. Manahan is an American gynecologist who is the current Chair of Obstetrics and Gynecology at the University of Toledo College of Medicine and Life Sciences in Toledo,Ohio.
Kenneth Offit is an American cancer geneticist and oncologist. He is currently Chief of the Clinical Genetics Service and the Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center. Offit is also a member of the Program in Cancer Biology and Genetics at the Sloan-Kettering Institute,Professor of Medicine and Healthcare Policy and Research at Weill Cornell Medical College,and a member of both the Board of Scientific Counselors of the National Cancer Institute and the Evaluation of Genomic Applications in Practice and Prevention working group of the U.S. Centers for Disease Control.
Eric P. Winer is a medical oncologist and clinical researcher specializing in breast cancer. He is director of Yale Cancer Center and president and physician-in-chief of Smilow Cancer Hospital Yale New Haven Health System,effective February 1,2022. He also is Deputy Dean for Cancer Research at Yale School of Medicine. From 1997 to 2021,he was the Chief of the Breast Oncology Program at Dana–Farber Cancer Institute in Boston,Massachusetts. Beginning in 2013,he held a range of institutional roles at Dana-Farber,including Chief of Clinical Development,the Thompson Chair in Breast Cancer Research and Director of the Dana-Farber/Harvard SPORE in Breast Cancer. He also served as a Professor of Medicine at Harvard Medical School. He was president of the American Society of Clinical Oncology (ASCO) 2022-2023 and became Chair of the Board in mid-June 2023. His career has been focused on breast cancer treatment and research.
Susan M. Domchek is an oncologist at the University of Pennsylvania,Executive Director of the Basser Center for BRCA,the Basser Professor in Oncology at the Perelman School of Medicine,and Director of the Mariann and Robert MacDonald Cancer Risk Evaluation Program at Penn Medicine. She has authored more than 250 articles in scholarly journals and serves on a number of editorial review boards. In 2018,Domchek was elected to the National Academy of Medicine.
Christina Messineo Annunziata is an American medical oncologist researching molecular signal transduction in ovarian cancer. She is an investigator in the National Cancer Institute's women's malignancies branch and head of the translational genomics section.
Allison Walsh Kurian is an American medical oncologist. She is a Professor of Medicine and Epidemiology &Population Health at Stanford University and an oncologist at the Stanford Cancer Institute.
Jung-Min Lee is a South Korean-American medical oncologist and physician-scientist focused on the early clinical drug development and translational studies of targeted agents in BRCA mutation-associated breast or ovarian cancer,high-grade epithelial ovarian cancer,and triple-negative breast cancer. She is a NIH Lasker Clinical Research Scholar and principal investigator in the Women's Malignancies Branch at the National Cancer Institute.
Lori Jo Pierce is an American radiation oncologist and 57th President of the American Society of Clinical Oncology. She is a Full Professor and Vice Provost for Academic and Faculty Affairs at the University of Michigan. Her research focuses on the use of radiotherapy in the multi-modality treatment of breast cancer,with emphasis on intensity modulated radiotherapy in node positive breast cancer,the use of radiosensitizing agents,and the outcomes of women treated with radiation for breast cancer who are carriers of a BRCA1/2 breast cancer susceptibility gene.
Stephanie Lynn Schutt Graff is an American breast medical oncologist. She is the Director of Breast Oncology at the Lifespan Cancer Institute and an Assistant Professor of Medicine at Alpert Medical School. Previously she was the Director of both the Breast Program and Clinical Research at Sarah Cannon Research Institute at HCA Midwest Health at Sarah Cannon Research Institute and Associate Director of the Breast Cancer Research Program at Sarah Cannon Research Institute.
Maura Lianne Gillison is an American medical oncologist and molecular epidemiologist. She is credited as the first investigator to establish a connection between HPV and oral cancer.
Kathleen R. Cho is an American gynecological surgical pathologist. She is a Professor of Pathology and Internal Medicine at Michigan Medicine.
Carol L. Brown is the Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering Cancer Center and a professor at Weill Cornell Medical College. She is a surgeon known for her work on gynecological cancers.
George Coukos is a physician-scientist in tumor immunology,professor and director of the Ludwig Cancer Research Lausanne Branch and director of the Department of oncology UNIL-CHUV of the University of Lausanne and the Lausanne University Hospital in Lausanne,Switzerland. He is known for his work on the mechanisms by which tumors suppress anti-cancer immune responses,and the role of the tumor vasculature in that suppression. In addition to his work in ovarian cancer,the combinatorial immune therapies proposed by Professor Coukos have been successfully tested and approved for lung,liver and kidney cancers.
Richard B. Gaynor is an American physician specializing in hematology-oncology,educator,drug developer,and business executive. He served as an Associate Professor of Medicine at UCLA School of Medicine for nearly a decade,and subsequently as an endowed Professor of Medicine and Microbiology at the University of Texas Southwestern Medical School prior to joining the pharmaceutical industry in 2002. His research on NF-κB,IκB kinase,and other mechanisms regulating viral and cellular gene expression has been covered in leading subject reviews. He has been a top executive at several pharmaceutical companies,with respect to the development and clinical testing of novel anticancer drugs and cell therapies. For over a decade and a half,he worked at Eli Lilly and Company,where he became the Senior Vice President of Oncology Clinical Development and Medical Affairs in 2013. Gaynor was President of R&D at Neon Therapeutics from 2016 to 2020,when he became the President of BioNTech US,both pharmaceutical companies headquartered in Cambridge,MA. His honors include being elected a member of the American Society for Clinical Investigation,and the Association of American Physicians.
Tara Olive Henderson is an American pediatric oncologist. As the Arthur and Marian Edelstein Professor in the Department of Pediatrics,she is also the Director of the Childhood Cancer Survivor Center,Director of Survivorship at the University of Chicago Comprehensive Cancer Center,and chief of Pediatric Hematology and Oncology at the University of Chicago.
References
- 1 2 3 "Beth Karlan CV" (PDF). uclahealth.org. UCLA. Retrieved April 2, 2021.
- ↑ "Blazing New Trails: Meet a Scientist". ocrahope.org. Ovarian Cancer Research Alliance. March 2020. Retrieved April 2, 2021.
- ↑ Walsh, Colleen (June 16, 2020). "Eight current Overseers share their unique stories". Harvard Gazette. Retrieved April 2, 2021.
- 1 2 "Beth Karlan, MD". uclahealth.org. UCLA. Retrieved April 2, 2021.
- ↑ "Awards". The Los Angeles Times. March 1, 1998. Retrieved April 2, 2021– via newspapers.com.
- ↑ Walsh, Christine S.; Karlan, Beth (February 1, 2010). "Molecular signatures of ovarian cancer: from detection to prognosis". Molecular Diagnosis & Therapy. 14 (1): 13–22. doi:10.1007/BF03256349. PMID 20121286. S2CID 22940887 . Retrieved April 2, 2021.
- ↑ "Six Presidential Appointees Named to National Cancer Advisory Board". ascopost.com. The ASCO Post. January 15, 2013. Retrieved May 1, 2021.
- ↑ "Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources Committee on Government Reform United States House of Representatives". gynecologiconcology-online.net. September 7, 2005. Retrieved May 1, 2021.
- 1 2 Gruen, Judy R. (October 22, 1998). "A Committed Life". Jewish Journal. Retrieved April 2, 2021.
- ↑ Leide, Alexander; Karlan, Beth Y.; Baldwin, Rae Lynn; Platt, Lawrence D.; Kuperstein, Graciela; Narod, Steven A. (2002). "Cancer incidence in a population of Jewish women at risk of ovarian cancer". Journal of Clinical Oncology . 20 (6): 1570–7. doi:10.1200/JCO.2002.20.6.1570. PMID 11896106 . Retrieved May 18, 2021.
- ↑ "BRCA initiative aims to increase access to testing". uclahealth.org. Retrieved April 2, 2021.
- ↑ "Congress Considers Bill for Gynecological Cancer Awareness". abcnews.go.com. ABC News. November 9, 2005. Retrieved May 1, 2021.
- ↑ "President Bush Signs H.R. 482, H.R. 1245, H.R. 4709, H.R. 4997, H.R. 5483, H.R. 5948, and H.R. 6338". presidency.ucsb.edu. January 12, 2007. Retrieved May 1, 2021.
- ↑ "Research and Markets: Surgery for Ovarian Cancer: Principles and Practice Second Edition". Business Wire. February 4, 2011. Retrieved June 20, 2021.
- ↑ "Dr. Beth Y. Karlan Named New Editor-in-Chief for Gynecologic Oncology". elsevier.com. January 16, 2008. Retrieved April 2, 2021.
- ↑ "Cedars-Sinai's Beth Karlan, MD, Named Editor-In-Chief Of Society Of Gynecologic Oncologists Medical Journal". cedars-sinai.org. September 21, 2007. Retrieved April 2, 2021.
- ↑ "IRIS International Elects Noted Cancer Expert, Dr. Beth Y. Karlan, to Board of Directors". May 27, 2009. Retrieved April 2, 2021.
- ↑ "Cedars-Sinai Physician Nominated by President Obama to National Cancer Advisory Board". cedars-sinai.org. December 12, 2012. Retrieved April 2, 2021.
- ↑ Gorman, Anna (May 15, 2013). "Angelina Jolie's choice is clear to one who faced it". Los Angeles Times. Retrieved April 2, 2021.
- ↑ "Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015". prweb.com. March 29, 2015. Retrieved April 2, 2021.
- ↑ "Rosalind Franklin Excellence in Ovarian Cancer Research Award". ocrahope.org. May 2015. Retrieved April 2, 2021.
- ↑ "Election Results". harvardmagazine.com. Harvard Magazine. August 2015. Retrieved April 2, 2021.
- ↑ "NAM Elects 80 New Members". nam.edu. National Academy of Medicine. October 19, 2015. Retrieved April 2, 2021.
- ↑ "Inaugural Giants of Science Los Angeles Gala honors Shannen Doherty, American Cancer Society funded researchers, NFL'S Chris Draft & gives boost to Moonshot Pledge". prweb.com. October 27, 2016. Retrieved April 2, 2021.
- ↑ "Beth Karlan, MD, Named Fellow of ASCO". cedars-sinai.edu. 2018. Retrieved April 2, 2021.
- ↑ "Dr. Beth Y. Karlan is New Chair of OCRA's Scientific Advisory Committee". ocrahope.org. February 26, 2019. Retrieved April 2, 2021.
- ↑ Heady, Denise (May 16, 2019). "Physician-scientist honored for work in oncology". newsroom.ucla.edu. UCLA. Retrieved April 2, 2021.
- ↑ "Two named to lead Overseers". Harvard Gazette. May 1, 2020. Retrieved April 2, 2021.
- ↑ "UCLA Joins Clinical Trial To Study COVID-19 In People With Cancer". nbclosangeles.com. September 14, 2020. Retrieved April 2, 2021.
- ↑ "Los Angeles' Top Doctors: Beth Karlan". Los Angeles Business Journal. January 20, 2021. Retrieved April 2, 2021.
- ↑ "Awards". International Gynecologic Cancer Society.
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
